Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis. [electronic resource]
Producer: 20040114Description: 238-42 p. digitalISSN:- 0361-8609
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Benzamides
- Female
- Humans
- Hydroxyurea -- therapeutic use
- Imatinib Mesylate
- Interferon-alpha -- therapeutic use
- Leukocytosis -- chemically induced
- Male
- Middle Aged
- Piperazines -- administration & dosage
- Polycythemia -- complications
- Primary Myelofibrosis -- drug therapy
- Pyrimidines -- administration & dosage
- Thrombocytosis -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.